ConductScience.org, home

Paper986308

Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984).

Braestrup C and 1 other. Eur J Pharmacol, 1976. Cited by 123 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984). Papers, record 986308. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/986308

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984).
PubMed
Journal
Eur J Pharmacol
PubMed
Year
1976
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
123
iCite
Relative citation ratio, by iCite
6.89
iCite
Revised in PubMed
2019-06-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Braestrup CC
2Scheel-Krüger JJ

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antidepressive AgentsMajor topic
IsoquinolinesMajor topic
MethylphenidateMajor topic
Animals
Apomorphine
Benztropine
Cocaine
Corpus Striatum
Dextroamphetamine
Dopamine
Humans
Male
Rats
Reserpine
Stereotyped Behavior
Synaptosomes
Time Factors

Source PubMed

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.

PMIDTitleJournalYearIn PapersSource
7,889,297Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.Br J Pharmacol1994https://conductscience.org/library/papers/7889297PubMed
7,241,163Nomifensine: effect in Parkinsonian patients not receiving levodopa.J Neurol Neurosurg Psychiatry1981https://conductscience.org/library/papers/7241163PubMed
6,725,869Multicentric experience on the acute effect of nomifensine in hyperprolactinemic women.J Endocrinol Invest1984https://conductscience.org/library/papers/6725869PubMed
6,408,155Nomifensine decreases the thyroid-stimulating-hormone response to thyrotropin-releasing-hormone in normal subjects.J Endocrinol Invest1983https://conductscience.org/library/papers/6408155PubMed
6,254,586Involvement of a central alpha-adrenoceptor system in antidepressant potentiation of hyperthermia induced by thyrotropin releasing hormone.Br J Pharmacol1980https://conductscience.org/library/papers/6254586PubMed
6,133,737Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.Drugs1983https://conductscience.org/library/papers/6133737PubMed
3,921,593Failure of nomifensine to reduce serum prolactin levels in patients with hepatic encephalopathy.J Endocrinol Invest1985https://conductscience.org/library/papers/3921593PubMed
3,561,528Effects of acute and chronic treatment with an atypical antidepressant drug, nomifensine, on the sleep-wake activity in rats.Naunyn Schmiedebergs Arch Pharmacol1987https://conductscience.org/library/papers/3561528PubMed
3,401,6374-Hydroxy-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline (PI-OH): a new potentiator of sympathomimetic amines on the rat anococcygeus muscle.Br J Pharmacol1988https://conductscience.org/library/papers/3401637PubMed
3,100,965Dopamine-like activities of an aminopyridazine derivative, CM 30366: a behavioural study.Naunyn Schmiedebergs Arch Pharmacol1986https://conductscience.org/library/papers/3100965PubMed
2,880,302(+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.Naunyn Schmiedebergs Arch Pharmacol1986https://conductscience.org/library/papers/2880302PubMed
2,693,054Rapid eye movement sleep and sleep continuity. Depression and antidepressants.Drugs1989https://conductscience.org/library/papers/2693054PubMed
2,541,855Potentiation by TRH of the effect of antidepressants in the forced-swimming test, involvement of dopaminergic and opioid systems.Br J Pharmacol1989https://conductscience.org/library/papers/2541855PubMed
2,409,454Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain.Naunyn Schmiedebergs Arch Pharmacol1985https://conductscience.org/library/papers/2409454PubMed
874,472Effect of nomifensine on central 5-hydroxytryptamine neurons.J Neural Transm1977https://conductscience.org/library/papers/874472PubMed
477,572Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness.Drugs1979https://conductscience.org/library/papers/477572PubMed
438,800Effect of mazindol on brain dopamine turnover in spiperone-treated rats.J Neural Transm1979https://conductscience.org/library/papers/438800PubMed
408,861Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression.Psychopharmacology (Berl)1977https://conductscience.org/library/papers/408861PubMed
334,231Review of the pharmacology of existing antidepressants.Br J Clin Pharmacol1977https://conductscience.org/library/papers/334231PubMed
334,223Nomifensine in Parkinson's disease.Br J Clin Pharmacol1977https://conductscience.org/library/papers/334223PubMed

See all 22 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/986308

GET https://conductscience.org/api/papers/v1/986308/cited_by?page=2